NEON THERAPEUTICS INC's ticker is NTGN and the CUSIP is 64050Y100. A total of 59 filers reported holding NEON THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $11,000 | +266.7% | 4,010 | +41.4% | 0.00% | – |
Q4 2019 | $3,000 | +50.0% | 2,835 | +166.2% | 0.00% | – |
Q3 2019 | $2,000 | -88.2% | 1,065 | -70.5% | 0.00% | – |
Q2 2019 | $17,000 | -39.3% | 3,612 | -15.7% | 0.00% | – |
Q1 2019 | $28,000 | +211.1% | 4,286 | +157.9% | 0.00% | – |
Q4 2018 | $9,000 | -40.0% | 1,662 | -5.8% | 0.00% | – |
Q3 2018 | $15,000 | – | 1,764 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 9,741,636 | $16,756,000 | 9.49% |
MYDA Advisors LLC | 155,000 | $267,000 | 0.12% |
Endurant Capital Management LP | 193,052 | $332,000 | 0.12% |
FNY Investment Advisers, LLC | 210,000 | $361,000 | 0.11% |
HARVARD MANAGEMENT CO INC | 505,871 | $870,000 | 0.08% |
Alambic Investment Management, L.P. | 25,800 | $44,000 | 0.03% |
OXFORD ASSET MANAGEMENT LLP | 209,307 | $360,000 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 155,619 | $268,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 116,600 | $201,000 | 0.00% |
Tower Research Capital LLC (TRC) | 14,371 | $25,000 | 0.00% |